Abstract
Traumatic brain injury (TBI) represents the leading cause of death among young people in developed countries. Due to its highly complex pathophysiology, no therapeutic drugs have been identified. Although a large number of patients with skeletal injuries requiring operative fixation sustain an associated TBI, the ideal timing and modality of fracture fixation in head-injured patients remains a topic of lively debate. While several groups advocate immediate definitive fracture fixation (“early total care”), others prefer the concept of “damage control orthopaedics” consisting of initial application of an external fixation and staged conversion to definitive internal fixation. In this chapter, we outline the pathophysiology of TBI and its impact on both fracture care and its associated clinical decision making.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Traumatic Brain Injury
- Glasgow Coma Scale
- External Fixation
- Severe Traumatic Brain Injury
- Traumatic Brain Injury Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
6.1 Pathophysiology of TBI
Despite modern intensive care strategies, the clinical outcome of severely head-injured patients remains poor [1–3]. The high mortality rates in this patient population are often attributed to the development of secondary insults to the injured brain [4–6]. While primary brain injury is a result of the mechanical forces applied to the skull at the time of impact, secondary brain injury evolves over time and thus cannot be detected on initial CT imaging studies [7, 8]. Evidence of secondary brain injury has been found on autopsy in 70–90% of all fatally head-injured patients [7, 9]. Secondary brain injury is initiated by a trauma-induced, host-mediated inflammatory response within the intracranial compartment [10–14], and is aggravated by hypoxia, metabolic acidosis, cerebral fat emboli from the fracture site, injury-triggered activation of the coagulation system, and development of cerebral edema [9, 15–19].
The immuno-patho physiological sequelae of Traumatic Brain Injury (TBI) are highly complex, and involve numerous brain-derived pro-inflammatory mediators, such as cytokines, chemokines, complement anaphylatoxins, excitatory molecules, electrolyte disturbances, and blood-derived leukocytes which are migrating across the blood–brain barrier [11, 20–24]. The resulting complex neuro-inflammatory network leads to a pro-inflammatory environment with brain edema and brain tissue destruction by leukocyte-released proteases, lipases, and reactive oxygen species. In addition, these events culminate in the breakdown of the blood–brain barrier and allow neurotoxic circulating molecules to enter the brain. As a result, the traumatized brain is highly susceptible to secondary injuries caused by intracerebral inflammation, as well as systemic neurotoxic molecules, which are normally “blocked” under physiological conditions (Fig. 6.1).
In TBI patients who have sustained concomitant major trauma to the musculoskeletal system, a profound systemic inflammatory response is also triggered in parallel, involving cytokines/chemokines, complement activation products, the coagulation system, stress hormones, neuronal signaling, and numerous inflammatory cells [25–30]. To date, we have an incomplete understanding of how the cerebral and systemic inflammatory responses interact and inter-communicate with each other, and whether there is “spill-over” from the intracerebral into the systemic “compartment” and vice versa, exacerbating the inflammatory response.
Consequently, the treating surgeon must be aware of the neuropathology of TBI as well as the systemic inflammatory events when deciding on the optimal management approach in this vulnerable patient population, as inappropriate treatment may result in an iatrogenic secondary insult to the brain [14, 31].
6.2 Clinical Assessment of TBI
On hospital admission, all head-injured patients are systemically assessed and resuscitated according to the American College of Surgeons’ Advanced Trauma Life Support (ATLS®) protocol. Closed head injury is typically diagnosed by (1) the history of trauma, (2) the clinical status, and (3) computed tomography (CT) scan. The neurologic status is assessed after stabilization of vital functions [17]. The level of consciousness is rapidly evaluated by the Glasgow Coma Scale (GCS), which grades the severity of TBI as mild (GCS 14/15), moderate (GCS 9–13), and severe (GCS 3–8) [17]. The post-resuscitation GCS score is of clinical importance due to the significant correlation with patient outcome [32]. A head CT should be obtained under the following circumstances: (1) altered level of consciousness with GCS <14 (moderate or severe brain injury), (2) abnormal neurological status, (3) differences in pupil size or reactivity, (4) suspected skull fracture, (5) intoxicated patients. The CT should be repeated whenever the patient’s neurologic status deteriorates [17]. During the initial management of TBI, hypoxemia, hypotension, hypercarbia, and hypoglycemia must be avoided or rapidly corrected to minimize the development of secondary brain damage [17]. Hemodynamic stability should be maintained using an isotonic electrolyte solution [33]. Maintenance of an adequate cerebral perfusion pressure (CPP = mean arterial pressure [MAP] – intracranial pressure [ICP]) above 70–80 mmHg is recommended in the early phase post trauma [17, 34, 35]. Cerebral edema should be rapidly addressed using osmotic drugs, and intracranial volume may be reduced by draining cerebrospinal fluid (CSF) via intra-ventricular catheters, or surgical hematoma evacuation.
Augmentation of the intravascular volume with osmotic therapeutics, such as mannitol, results in a transient increase in MAP and CPP and induces cerebral vasoconstriction, reducing the intracranial volume [17]. Osmotic therapy using mannitol or hypertonic saline is currently recommended if the patient displays clinical signs of trans-tentorial herniation, progressive neurological deterioration, or bilaterally dilated and nonreactive pupils [17]. Results of the Corticosteroid Randomization after Significant Head Injury (CRASH) trial have made the use of gluco-corticoids obsolete and contrast indicated in severely head-injured patients [36, 37].
Intra-ventricular catheters are used to monitor intracranial pressures and allow CSF drainage to decrease the ICP [35]. Current guidelines recommend continuous ICP monitoring in patients (1) with severe head injury (GCS < 9) and abnormal admission CT scan; (2) with severe head injury (GCS < 9) and normal initial CT scan, but with a prolonged coma >6 h; (3) requiring evacuation of intracranial hematomas; (4) with neurological deterioration (GCS < 9) in patients with initially mild or moderate head injury; and (5) head-injured patients requiring prolonged mechanical ventilation, unless the initial CT scan is normal [17, 34, 38, 39].
Craniotomy with evacuation of intracranial mass lesion must be undertaken as soon as possible in patients with clinically relevant and surgically accessible hematomas [92]. Elevated intracranial pressure is one of the most common causes of death and disability in the severely brain-injured patient. When intracranial hypertension is refractory to medical treatment, many patients undergo decompressive craniectomy. However, the indication, timing, and method of decompressive craniectomy are not well defined [40, 41]. Recent literature suggests that hinge craniectomy achieves similar outcomes with respect to ICP control and early outcomes when compared to standard decompressive craniectomy [40]. An additional benefit of this modality is that patients will not have to undergo a delayed cranioplasty for skull defect closure.
6.3 Strategies of Fracture Fixation in TBI Patients
Choosing the ideal timing and modality of fracture fixation in head-injured patients is of paramount importance to avoid a detrimental “second hit” injury to the brain [14, 42]. However, selecting a “safe” treatment modality of the multiply injured patient with concomitant TBI can be difficult.
The initial assessment and management of any trauma patient with TBI should follow the ATLS® algorithm [25, 43]. Hypoxemia and hypotension, the “lethal duo of TBI” [44], need to be avoided at all times, as both will exacerbate post-traumatic edema with potentially detrimental consequences [33]. Adequate oxygenation, appropriate fluid resuscitation, and maintenance of the CCP above 70 mmHg are of paramount importance [33, 45].
To best achieve these goals in multiply injured patients with TBI, modern ventilation strategies and damage control resuscitation principles have been developed, aiming to avoid overly aggressive fluid management exacerbating cerebral edema, respectively [46–50.Glucose-containing crystalloid fluids should be avoided in TBI patients, as hyperglycemia induces local acidosis and oxidative stress, promotes edema formation, impairs nitric oxide-mediated vasodilation, and triggers inflammation [51–53]. Arterial blood glucose values between 6 and 8 mmol/L are currently considered ideal in patients with severe TBI [54].
During the first 24 h post trauma, any unnecessary surgical interventions may negatively alter the patient’s MAP and lower the CCP [55]. As a result, surgical intervention should be limited to emergency procedures and “damage control” procedures for hemodynamically unstable patients in extremis,such as emergent laparotomy, pelvic external fixation, and pelvic packing [25, 43, 55].
Definitive fracture management in traction is currently considered obsolete, as any non-stabilized fracture greatly increases the “antigenic load” (pain and stress) of trauma. Such a management approach exacerbates systemic inflammation and intracranial edema, and allows fat emboli from the fracture site to circulate, aggravating the patient’s secondary brain injuries [25, 26, 56, 57]. Moreover, the lack of adequate positioning and mobilization put the patient at risk for pressure sores, thrombo-embolic events, and pulmonary complications. Thus, modern treatment strategies favor early fracture fixation, to reduce the “antigenic load,” allow early mobilization and adequate positioning options in the ICU, and help prevent pulmonary complications [43, 58]. Nevertheless, the ideal timing of definitive femur fixation remains a topic of lively debate and no authoritative, evidence-based guidelines exist [59, 60].
To date, there are two conflicting philosophies for the ideal timing of operative fracture fixation once hemodynamic stabilization is achieved and trauma-induced neuropathology is addressed. Several groups favor an “early total care” approach with immediate definitive fracture fixation within the first 24 h [64]. Others advocate the staged “damage control” notion that supports immediate temporary fracture stabilization by means of external fixation and delayed definitive fracture fixation once resuscitation endpoints are met [43, 86, 91]. This operative “window of opportunity” for definitive fracture fixation is currently considered to be between day 5 and 10 after injury [25, 26, 43, 56]. However, the pertinent literature fails to identify an evidence-based ideal strategy for the optimal time-point of definitive fracture fixation in patients with associated TBI. Several groups report that timing of definitive fracture fixation in patients with TBI and associated femoral fractures does not influence morbidity, mortality, or neurological outcome [61–67].
Authors advocating the “early total care” concept report decreased mortality and superior outcome if definitive fracture fixation occurs within the first 24–48 h of admission [58, 68], even in the co-presence of associated combined chest and head injuries [69, 70]. In addition, the incidence of complications and pulmonary morbidities, and ICU length of stay were all found to be reduced when patients were definitively treated within 24 h [58, 71–74].
In contrast, supporters of “damage control orthopaedics” (DCO) base their surgical decision making on a patho-physiological standpoint, and consider the inadequately resuscitated patient already in jeopardy of the “lethal triad,” i.e., metabolic acidosis, hypothermia, and coagulopathy [75]. As a result, DCO supports a staged surgical approach in TBI patients with associated fractures, with immediate external stabilization as a bridge toward eventual definitive fixation during the “window of opportunity” once the patient is hemodynamically stable, fully resuscitated, and the hyper-inflammatory response subsides [31, 43, 55, 76]. Furthermore, advocates of DCO claim that an “early total care” approach prolongs operative times, significantly increases intracranial pressures [77, 78], decreases cerebral perfusion pressures [79–81], and causes cerebral micro-emboli due to immediate fracture care [82]. These patho-physiological changes may result in an iatrogenic amplification of secondary brain injury [77, 79, 80, 83, 84]. Moreover, early intramedullary fracture fixation creates a higher pulmonary embolic load than primary external fixation [85], and may cause serious pulmonary complications [86, 87]. Based on these observations, the DCO concept favors immediate temporary stabilization <24 h via external fixation, early transfer to intensive care, hemodynamic stabilization, and acute resuscitation [31, 55]. Definitive surgical fracture fixation is then planned on an elective basis once the patient meets the following “endpoints of resuscitation” [43]:
-
Stable hemodynamics without the need for vasoactive or inotropic stimulation
-
No hypoxemia or hypercapnia
-
Serum lactate < 2.5 mmol/L
-
Normal coagulation (INR, TEG)
-
Normothermia
-
Normal urinary output (>1 mL/kg/h)
These parameters are usually reached within the “window of opportunity” (day 5–10 post trauma), and favorable results have been described when external fixation is converted to definitive fracture fixation within the first 2 weeks [88].
6.4 Conclusion
Head-injured patients with concomitant fractures represent a highly vulnerable patient population. An initially undiagnosed TBI can result in secondary evolution of intracranial hemorrhages or cerebral edema, as exemplified by the patient who “talks and dies” [17]. Involving multiple disciplines, including trauma surgeons, neurosurgeons, ICU anesthetists, as well as orthopaedic trauma surgeons allows for a best possible outcome. The current literature is conflicting and fails to identify an unequivocal management strategy [89, 90], underscoring the pressing need for large, randomized multicenter trails to evaluate the concept of DCO in TBI patients with fractures vs. “early total care.”
When the patient with combined orthopedic and neurosurgical injuries is evaluated in the emergency department, several questions need to be answered. A rapid neurologic exam should be performed to assess the severity of brain injury. If the patient is hemodynamically stable, then a non-contrast CT brain should be performed. If the patient is hemodynamically unstable, then an ICP monitor (either fiberoptic or ventricular) may be placed in the ED. In the patient with lateralizing signs, an air ventriculogram may be helpful to evaluate for mass lesions (may be performed in the ED or OR).
Any patient with a suspected brain injury who needs to be taken to the operating room and will be unable to undergo follow up neurologic examination requires ICP monitoring. The exact ICP threshold of when not to proceed to the operating room is unknown, though sustained pressures beyond 15 mmHg should be an indication to proceed to the ICU for resuscitation. Any patient with a progressively worsening neurological exam is also at high risk as is the patient with unexplained changes in ICP. Hypoxia and hypotension significantly increase mortality in the patient with brain injury.
Until clear-cut, evidence-based recommendations are established, the clinical approach needs to be based on knowledge of physiology, logic and the accumulated experience. We recommend the following management strategy for orthopaedic injuries in head-injured patients [91]:
-
1.
Early total care in all patients with mild TBI (GCS 14/15 points), and normal craniocerebral CT scan, unless IMN contraindicated (e.g., severe chest injury, traumatic-hemorrhagic shock, etc.).
-
2.
Damage control orthopaedics by means of external femur fixation in all patients with severe TBI (GCS ≤8 points, presence of significant intracranial pathology on CT scan, such as edema, midline shift, sub-/epidural bleeding, open head injury with intracranial air). Concomitant procedures may be performed (emergency craniotomy at same time as DCO).
-
3.
Consider damage control orthopaedics in all patients with moderate TBI (GCS 9–13 points), or patients with GCS of 14 or 15 with “minor” intracranial pathology on CT scan (e.g., traumatic subarachnoid bleeding, extra-axial hematomas that warrant observation only).
-
4.
No additional operation for patients with refractory intracranial hypertension or unexplained change in neurologic exam,
-
5.
Conversion from external to internal fixation in TBI patients who recovered from a comatose state and are awake and alert (GCS >12) or comatose patients with a stable ICP (<20 mmHg) and CPP (>80 mmHg) for more than 48 h.
References
Graham DI, McIntosh TK, Maxwell WL, et al. Recent advances in neurotrauma. J Neuropathol Exp Neurol. 2000;59:641–51.
Koponen S, Taiminen T, Portin R, et al. Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry. 2002;159:1315–21.
Maas AI, Dearden M, Servadei F, et al. Current recommendations for neurotrauma. Curr Opin Crit Care. 2000;6:281–92.
Orliaguet GA, Meyer PG, Baugnon T. Management of the critically ill children with traumatic brain injury. Paediatr Anaesth. 2008;18(6):455–61.
Bayir H, Clark RS, Kochanek PM. Promising strategies to minimize secondary brain injury after head trauma. Crit Care Med. 2003;31:S112–7.
Masson F, Thicoipe M, Aye P, et al. Epidemiology of severe brain injuries: a prospective population-based study. J Trauma. 2001;51:481–9.
Morganti-Kossmann MC, Rancan M, Otto VI, et al. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock. 2001;16:165–77.
Schmidt OI, Heyde CE, Ertel W, Stahel PF. Closed head injury – an inflammatory disease? Brain Res Brain Res Rev. 2005;48:388–99.
Finfer SR, Cohen J. Severe traumatic brain injury. Resuscitation. 2001;48:77–90.
Baethmann A, Lehr D, Wirth A. Prospective analysis of patient management in severe head injury. Acta Neurochir Suppl. 1998;71:107–10.
Ghirnikar RS, Lee YL, Eng LF. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res. 1998;23:329–40.
Morganti-Kossman MC, Rancan M, Stahel P, et al. Inflammatory responses to traumatic brain injury: an overview for the new millennium. In: Rothwell NJ, Loddick S, editors. Immune and inflammatory responses in the nervous system. 2nd ed. Oxford: Oxford University Press; 2002. pp. 106–26.
Neugebauer E, Hensler T, Rose S, et al. Severe craniocerebral trauma in multiple trauma. An assessment of the interaction of local and systemic mediator responses. Unfallchirurg. 2000;103:122–31.
Elf K, Nilsson P, Enblad P. Prevention of secondary insults in neurointensive care of traumatic brain injury. Eur J Trauma. 2003;29:74–80.
Golding EM. Sequelae following traumatic brain injury. The cerebrovascular perspective. Brain Res Brain Res Rev. 2002;38:377–88.
Rosomoff HL, Kochanek PM, Clark R, et al. Resuscitation from severe brain trauma. Crit Care Med. 1996;24:S48–56.
Stahel PF, Smith WR. Closed head injury. In: Bland KI, Büchler MW, Csendes A, et al., editors. General surgery: principles and international practice. 2nd ed. London: Springer; 2009. p. 131–42.
Jeremitsky E, Omert L, Dunham CM, et al. Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion. J Trauma. 2003;54:312–9.
Wu XH, Shi XY, Gan JX, et al. Dynamically monitoring tissue factor and tissue factor pathway inhibitor following secondary brain injury. Chin J Traumatol. 2003;6:114–7.
Ransohoff RM. Chemokines in neurological trauma models. Ann NY Acad Sci. 2002;961:346–9.
Ransohoff RM. The chemokine system in neuroinflammation: an update. J Infect Dis. 2002;186 Suppl 2:S152–6.
Stahel PF, Morganti-Kossmann MC, Kossmann T. The role of the complement system in traumatic brain injury. Brain Res Rev. 1998;27:243–56.
Zhuang J, Shackford SR, Schmoker JD, et al. The association of leukocytes with secondary brain injury. J Trauma. 1993;35:415–22.
Schoettle RJ, Kochanek PM, Magargee MJ, et al. Early polymorphonuclear leukocyte accumulation correlates with the development of posttraumatic cerebral edema in rats. J Neurotrauma. 1990;7:207–17.
Gebhard F, Huber-Lang M. Polytrauma-pathophysiology and management principles. Langenbecks Arch Surg. 2008;393(6):825–31.
Stahel PF, Smith WR, Moore EE. Role of biological modifiers regulating the immune response after trauma. Injury. 2007;38:1409–22.
Woolf PD. Hormonal responses to trauma. Crit Care Med. 1992;20:216–26.
Tracey KJ. The inflammatory reflex. Nature. 2002;420:853–9.
Tracey KJ, Czura CJ, Ivanova S. Mind over immunity. FASEB J. 2001;15:1575–6.
Arand M, Melzner H, Kinzl L, et al. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans. Langenbecks Arch Surg. 2001;386:241–8.
Grotz MR, Giannoudis PV, Pape HC, et al. Traumatic brain injury and stabilisation of long bone fractures: an update. Injury. 2004;35:1077–86.
Davis DP, Serrano JA, Vilke GM, et al. The predictive value of field versus arrival Glasgow Coma Scale score and TRISS calculations in moderate-to-severe traumatic brain injury. J Trauma. 2006;60:985–90.
Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation. J Neurotrauma. 2007;24 Suppl 1:S7–13.
Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds. J Neurotrauma. 2007;24 Suppl 1:S55–8.
Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring. J Neurotrauma. 2007;24 Suppl 1:S37–44.
Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365:1957–9.
Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364:1321–8.
Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma. 2007;24 Suppl 1:S59–64.
Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure monitoring technology. J Neurotrauma. 2007;24 Suppl 1:S45–54.
Kenning TJ, Gandhi RH, German JW. A comparison of hinge craniotomy and decompressive craniectomy for the treatment of malignant intracranial hypertension: early clinical and radiographic analysis. Neurosurg Focus. 2009;26:E6.
Paci GM, Sise MJ, Sise CB, et al. Preemptive craniectomy with craniotomy: what role in the management of severe traumatic brain injury? J Trauma. 2009;67:531–6.
Leker RR, Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev. 2002;39:55–73.
Stahel PF, Smith WR, Moore EE. Current trends in resuscitation strategy for the multiply injured patient. Injury. 2009;40 Suppl 4:S27–35.
Stahel PF, Smith WR, Moore EE. Hypoxia and hypotension, the “lethal duo” in traumatic brain injury: implications for prehospital care. Intensive Care Med. 2008;34:402–4.
Stiefel MF, Udoetuk JD, Storm PB, et al. Brain tissue oxygen monitoring in pediatric patients with severe traumatic brain injury. J Neurosurg. 2006;105:281–6.
Sagraves SG, Toschlog EA, Rotondo MF. Damage control surgery – the intensivist’s role. J Intensive Care Med. 2006;21:5–16.
Spinella PC, Priestley MA. Damage control mechanical ventilation: ventilator induced lung injury and lung protective strategies in children. J Trauma. 2007;62:S82–3.
Holcomb JB. Damage control resuscitation. J Trauma. 2007;62:S36–7.
Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307–10.
Spahn DR, Cerny V, Coats TJ, et al. Management of bleeding following major trauma: a European guideline. Crit Care. 2007;11:R17.
Diaz-Parejo P, Stahl N, Xu W, et al. Cerebral energy metabolism during transient hyperglycemia in patients with severe brain trauma. Intensive Care Med. 2003;29:544–50.
Garg R, Chaudhuri A, Munschauer F, et al. Hyperglycemia, insulin, and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke. 2006;37:267–73.
Kinoshita K, Kraydieh S, Alonso O, et al. Effect of posttraumatic hyperglycemia on contusion volume and neutrophil accumulation after moderate fluid-percussion brain injury in rats. J Neurotrauma. 2002;19:681–92.
Holbein M, Bechir M, Ludwig S, et al. Differential influence of arterial blood glucose on cerebral metabolism following severe traumatic brain injury. Crit Care. 2009;13:R13.
Stahel PF, Ertel W, Heyde CE. Traumatic brain injury: impact on timing and modality of fracture care. Orthopade. 2005;34:852–64.
Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36:691–709.
Rose S, Marzi I. Mediators in polytrauma – pathophysiological significance and clinical relevance. Langenbecks Arch Surg. 1998;383:199–208.
Bone LB, Johnson KD, Weigelt J, et al. Early versus delayed stabilization of femoral fractures. A prospective randomized study. J Bone Joint Surg Am. 1989;71:336–40.
Bose D, Tejwani NC. Evolving trends in the care of polytrauma patients. Injury. 2006;37:20–8.
Giannoudis PV, Veysi VT, Pape HC, et al. When should we operate on major fractures in patients with severe head injuries? Am J Surg. 2002;183:261–7.
Kalb DC, Ney AL, Rodriguez JL, et al. Assessment of the relationship between timing of fixation of the fracture and secondary brain injury in patients with multiple trauma. Surgery. 1998;124:739–44; discussion 744-735.
Velmahos GC, Arroyo H, Ramicone E, et al. Timing of fracture fixation in blunt trauma patients with severe head injuries. Am J Surg. 1998;176:324–9; discussion 329–330.
Wang MC, Temkin NR, Deyo RA, et al. Timing of surgery after multisystem injury with traumatic brain injury: effect on neuropsychological and functional outcome. J Trauma. 2007;62:1250–8.
Bhandari M, Guyatt GH, Khera V, et al. Operative management of lower extremity fractures in patients with head injuries. Clin Orthop Relat Res. 2003;407:187–98.
Kotwica Z, Balcewicz L, Jagodzinski Z. Head injuries coexistent with pelvic or lower extremity fractures – early or delayed osteosynthesis. Acta Neurochir (Wien). 1990;102:19–21.
Poole GV, Miller JD, Agnew SG, et al. Lower extremity fracture fixation in head-injured patients. J Trauma. 1992;32:654–9.
Reynolds MA, Richardson JD, Spain DA, et al. Is the timing of fracture fixation important for the patient with multiple trauma? Ann Surg. 1995;222:470–8; discussion 478–481.
Hofman PA, Goris RJ. Timing of osteosynthesis of major fractures in patients with severe brain injury. J Trauma. 1991;31:261–3.
Nau T, Aldrian S, Koenig F, et al. Fixation of femoral fractures in multiple-injury patients with combined chest and head injuries. ANZ J Surg. 2003;73:1018–21.
Brundage SI, McGhan R, Jurkovich GJ, et al. Timing of femur fracture fixation: effect on outcome in patients with thoracic and head injuries. J Trauma. 2002;52:299–307.
Seibel R, LaDuca J, Hassett JM, et al. Blunt multiple trauma (ISS 36), femur traction, and the pulmonary failure-septic state. Ann Surg. 1985;202:283–95.
Johnson KD, Cadambi A, Seibert GB. Incidence of adult respiratory distress syndrome in patients with multiple musculoskeletal injuries: effect of early operative stabilization of fractures. J Trauma. 1985;25:375–84.
Charash WE, Fabian TC, Croce MA. Delayed surgical fixation of femur fractures is a risk factor for pulmonary failure independent of thoracic trauma. J Trauma. 1994;37:667–72.
Starr AJ. Timing fracture repair in patients with severe brain injury (Glasgow Coma Scale score <9). J Trauma. 1998;45:980.
Stahel PF, Moore EE, Schreier SL, et al. Transfusion strategies in postinjury coagulopathy. Curr Opin Anaesthesiol. 2009;22:289–98.
Lehmann U, Rickels E, Krettek C. Multiple trauma with craniocerebral trauma. Early definitive surgical management of long bone fractures? Unfallchirurg. 2001;104:196–209.
Mousavi M, Kolonja A, Schaden E, et al. Intracranial pressure-alterations during controlled intramedullary reaming of femoral fractures: an animal study. Injury. 2001;32:679–82.
Lehmann U, Reif W, Hobbensiefken G, et al. Effect of primary fracture management on craniocerebral trauma in polytrauma. An animal experiment study. Unfallchirurg. 1995;98:437–41.
Anglen JO, Luber K, Park T. The effect of femoral nailing on cerebral perfusion pressure in head-injured patients. J Trauma. 2003;54:1166–70.
Townsend RN, Lheureau T, Protech J, et al. Timing fracture repair in patients with severe brain injury (Glasgow Coma Scale score <9). J Trauma. 1998;44:977–82; discussion 982-973.
Jaicks RR, Cohn SM, Moller BA. Early fracture fixation may be deleterious after head injury. J Trauma. 1997;42:1–5; discussion 5-6.
Forteza AM, Koch S, Romano JG, et al. Transcranial Doppler detection of fat emboli. Stroke. 1999;30:2687–91.
Giannoudis PV, Pape HC, Cohen AP, et al. Review: systemic effects of femoral nailing: from Kuntscher to the immune reactivity era. Clin Orthop Relat Res. 2002;404:378–86.
Harwood PJ, Giannoudis PV, van Griensven M, et al. Alterations in the systemic inflammatory response after early total care and damage control procedures for femoral shaft fracture in severely injured patients. J Trauma. 2005;58:446–52; discussion 452-444.
Gray AC, White TO, Clutton E, et al. The stress response to bilateral femoral fractures: a comparison of primary intramedullary nailing and external fixation. J Orthop Trauma. 2009;23:90–7; discussion 98–99.
Pape HC. Effects of changing strategies of fracture fixation on immunologic changes and systemic complications after multiple trauma: damage control orthopedic surgery. J Orthop Res. 2008;26:1478–84.
Pape HC, Rixen D, Morley J, et al. Impact of the method of initial stabilization for femoral shaft fractures in patients with multiple injuries at risk for complications (borderline patients). Ann Surg. 2007;246:491–9; discussion 499–501.
Nowotarski PJ, Turen CH, Brumback RJ, et al. Conversion of external fixation to intramedullary nailing for fractures of the shaft of the femur in multiply injured patients. J Bone Joint Surg Am. 2000;82:781–8.
Scalea TM. Optimal timing of fracture fixation: have we learned anything in the past 20 years? J Trauma. 2008;65:253–60.
Rixen D, Grass G, Sauerland S, et al. Evaluation of criteria for temporary external fixation in risk-adapted damage control orthopedic surgery of femur shaft fractures in multiple trauma patients: “evidence-based medicine” versus “reality” in the trauma registry of the German Trauma Society. J Trauma. 2005;59:1375–94; discussion 1394-1375.
Flierl MA, Stoneback JW, Beauchamp KM, et al. Femur shaft fracture fixation in head-injured patients – when is the right time? J Orthop Trauma. 2010;24:107–14.
Marinkovic I, Strbian D, Pedrono E, et al. Decompressive craniectomy for intracerebral hemorrhage. Neurosurgery. 2009;65:780–86; 781 p following 786; discussion 786.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Flierl, M.A., Beauchamp, K.M., Stahel, P.F. (2011). Head Injuries: Neurosurgical and Orthopaedic Strategies. In: Pape, HC., Sanders, R., Borrelli, Jr., J. (eds) The Poly-Traumatized Patient with Fractures. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-17986-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-17986-0_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-17985-3
Online ISBN: 978-3-642-17986-0
eBook Packages: MedicineMedicine (R0)